87 related articles for article (PubMed ID: 17396728)
21. Decline in macrolide-resistant Streptococcus pyogenes isolates from French children.
d'Humières C; Cohen R; Levy C; Bidet P; Thollot F; Wollner A; Bingen E
Int J Med Microbiol; 2012 Dec; 302(7-8):300-3. PubMed ID: 23103047
[TBL] [Abstract][Full Text] [Related]
22. Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California.
York MK; Gibbs L; Perdreau-Remington F; Brooks GF
J Clin Microbiol; 1999 Jun; 37(6):1727-31. PubMed ID: 10325315
[TBL] [Abstract][Full Text] [Related]
23. Emergence of macrolide-resistant Streptococcus pyogenes strains in French children.
Bingen E; Bidet P; Mihaila-Amrouche L; Doit C; Forcet S; Brahimi N; Bouvet A; Cohen R
Antimicrob Agents Chemother; 2004 Sep; 48(9):3559-62. PubMed ID: 15328126
[TBL] [Abstract][Full Text] [Related]
24. Macrolide and Clindamycin Resistance in Group a Streptococci Isolated From Children With Pharyngitis.
DeMuri GP; Sterkel AK; Kubica PA; Duster MN; Reed KD; Wald ER
Pediatr Infect Dis J; 2017 Mar; 36(3):342-344. PubMed ID: 27902646
[TBL] [Abstract][Full Text] [Related]
25. Association between resistance to erythromycin and the presence of the fibronectin binding protein F1 gene, prtF1, in Streptococcus pyogenes isolates from German pediatric patients.
Haller M; Fluegge K; Arri SJ; Adams B; Berner R
Antimicrob Agents Chemother; 2005 Jul; 49(7):2990-3. PubMed ID: 15980381
[TBL] [Abstract][Full Text] [Related]
26. The change of macrolide resistance rates in group A Streptococcus isolates from children between 2002 and 2013 in Asahikawa city.
Sakata H
J Infect Chemother; 2015 May; 21(5):398-401. PubMed ID: 25618777
[TBL] [Abstract][Full Text] [Related]
27. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh.
Martin JM; Green M; Barbadora KA; Wald ER
N Engl J Med; 2002 Apr; 346(16):1200-6. PubMed ID: 11961148
[TBL] [Abstract][Full Text] [Related]
28. [Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
Rodríguez-Zurita ME; Solís del Baño S; Robres Guillén P; González Praetorius A; Gimeno Fernández C; Pérez Pomata MT; Bisquert Santiago J
Rev Esp Quimioter; 2003 Mar; 16(1):61-4. PubMed ID: 12750759
[TBL] [Abstract][Full Text] [Related]
29. Macrolide prescriptions and erythromycin resistance of Streptococcus pyogenes.
Gagliotti C; Nobilio L; Milandri M; Moro ML;
Clin Infect Dis; 2006 Apr; 42(8):1153-6. PubMed ID: 16575736
[TBL] [Abstract][Full Text] [Related]
30. High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China.
Liu X; Shen X; Chang H; Huang G; Fu Z; Zheng Y; Wang L; Li C; Liu L; Shen Y; Yang Y
Pediatr Pulmonol; 2009 May; 44(5):436-41. PubMed ID: 19360846
[TBL] [Abstract][Full Text] [Related]
31. Rapid decrease in the prevalence of macrolide-resistant group A streptococci due to the appearance of two epidemic clones in Cantabria (Spain).
Oliver MA; García-Delafuente C; Cano ME; Pérez-Hernández F; Martínez-Martínez L; Albertí S
J Antimicrob Chemother; 2007 Aug; 60(2):450-2. PubMed ID: 17540676
[No Abstract] [Full Text] [Related]
32. Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types.
Michos AG; Bakoula CG; Braoudaki M; Koutouzi FI; Roma ES; Pangalis A; Nikolopoulou G; Kirikou E; Syriopoulou VP
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):295-9. PubMed ID: 19395219
[TBL] [Abstract][Full Text] [Related]
33. [Macrolide resistance phenotypes and genotypes in group G streptococci].
Açikgöz ZC; Göçer S; Almayanlar E
Mikrobiyol Bul; 2003; 37(2-3):117-24. PubMed ID: 14593892
[TBL] [Abstract][Full Text] [Related]
34. Macrolide resistance mechanisms and in vitro susceptibility patterns of viridans group streptococci isolated from blood cultures.
Ergin A; Ercis S; Hasçelik G
J Antimicrob Chemother; 2006 Jan; 57(1):139-41. PubMed ID: 16291867
[TBL] [Abstract][Full Text] [Related]
35. Erythromycin resistance in Streptococcus pyogenes and macrolide consumption in a central Italian region.
Montagnani F; Stolzuoli L; Croci L; Rizzuti C; Arena F; Zanchi A; Cellesi C
Infection; 2009 Aug; 37(4):353-7. PubMed ID: 19137242
[TBL] [Abstract][Full Text] [Related]
36. [Resistance to macrolides in the species Streptococcus pyogenes in the Czech Republic in 1996-2003].
Urbásková P; Jakubů V;
Epidemiol Mikrobiol Imunol; 2004 Nov; 53(4):196-202. PubMed ID: 15633541
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infections.
Ikebe T; Hirasawa K; Suzuki R; Isobe J; Tanaka D; Katsukawa C; Kawahara R; Tomita M; Ogata K; Endoh M; Okuno R; Watanabe H
Antimicrob Agents Chemother; 2005 Feb; 49(2):788-90. PubMed ID: 15673769
[TBL] [Abstract][Full Text] [Related]
38. [Resistance phenotypes and genotypes of Streptococcus pyogenes clinical isolates in Chile over a 10-year period].
Rodríguez C; Rojas P; Wozniak A; Kalergis AM; Cerón I; Riedel I; Román JC; Villarroel LA; Berríos X; Bavestrello L; García P
Rev Med Chil; 2011 Sep; 139(9):1143-9. PubMed ID: 22215392
[TBL] [Abstract][Full Text] [Related]
39. Antibiotic susceptibility of group A streptococci in 2 Italian cities: Milano and Catania.
Cocuzza C; Blandino G; Mattina R; Nicoletti F; Nicoletti G
Microb Drug Resist; 1997; 3(4):379-84. PubMed ID: 9442491
[TBL] [Abstract][Full Text] [Related]
40. Macrolide, lincosamide and tetracycline susceptibility and emm characterisation of invasive Streptococcus pyogenes isolates in Israel.
Nir-Paz R; Block C; Shasha D; Korenman Z; Gorodnitzky Z; Jaffe J; Ron M; Michael-Gayego A; Cohen-Poradosu R; Shapiro M; Moses AE
Int J Antimicrob Agents; 2006 Oct; 28(4):313-9. PubMed ID: 16973336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
